Icu Medical share price today
(NASDAQ: ICUI)

Name: Icu Medical Share Price Today (NASDAQ: ICUI) - Icu Medical Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Icu Medical share price is $167.12 & ₹14,454.21 as on 24 Jan 2025, 2.30 'hrs' IST

$167.12

▲

0.11

(0.07%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Icu Medical share price in Dollar and Rupees. Guide to invest in Icu Medical stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Icu Medical, along with analyst recommendations, forecasts, and comprehensive financials.

Icu Medical share price movements

Today's Low: $162.38
Today's High: $167.15
$167.12
2.84%
Downside
Day's Volatility :2.85%
Upside
0.01%
52 Weeks Low: $86.80
52 Weeks High: $196.26
$167.12
48.06%
Downside
52 Weeks Volatility :55.77%
Upside
14.85%

Icu Medical Returns

Period	Icu Medical Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-4.87%	-5.5%	0.0%
6 Months	30.45%	-4.3%	0.0%
1 Year	74.4%	1.6%	0.0%
3 Years	-19.58%	9.8%	-11.0%

Icu Medical Key Statistics

in dollars & INR

Previous Close	$167.01
Open	$165.93
Today's High	$167.145
Today's Low	$162.38
Market Capitalization	$4.1B
Today's Volume	$203.5K
52 Week High	$196.2607
52 Week Low	$86.8
Revenue TTM	$2.3B
EBITDA	$269.6M
Earnings Per Share (EPS)	$-4.56
Profit Margin	-4.74%
Quarterly Earnings Growth YOY	-0.24%
Return On Equity TTM	-5.35%

How to invest in Icu Medical Stock (ICUI) from India?

It is very easy for Indian residents to invest directly in Icu Medical from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Icu Medical stock in both Indian Rupees (INR) and US Dollars (USD). Search for Icu Medical or ICUI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Icu Medical or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Icu Medical shares which would translate to 0.005 fractional shares of Icu Medical as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Icu Medical, in just a few clicks!

Returns in Icu Medical for Indian investors in Rupees

Investment Value

₹1,00,000

Icu Medical investment value today

Current value as on today

₹1,78,574

Returns

₹78,574

(+78.57%)

Returns from Icu Medical Stock

₹74,520 (+74.52%)

Dollar Returns

₹4,054 (+4.05%)

Indian investors sentiment towards Icu Medical

33%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Icu Medical on INDmoney from India has grown in the last 30 days as on Jan 24, 2025. 33% more investors are searching Icu Medical in the last 30 days versus the previous period.

Global Institutional Holdings in Icu Medical

BlackRock Inc
14.91%
Vanguard Group Inc
10.88%
HHG PLC
9.85%
Fuller & Thaler Asset Management Inc
5.77%
Wellington Management Company LLP
3.83%
State Street Corp
3.71%

Analyst Recommendation on Icu Medical

Buy

80%Buy

20%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Icu Medical(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Icu Medical

What analysts predicted

Upside of 21.71%

Target:

$203.40

Current:

$167.12

Insights on Icu Medical

Price Movement
In the last 1 year, ICUI stock has moved up by 74.4%
Decreasing Revenue
Revenue is down for the last 2 quarters, 596.45M → 589.13M (in $), with an average decrease of 1.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -21.40M → -32.98M (in $), with an average decrease of 54.1% per quarter
ICUI vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 126.5% return, outperforming this stock by 147.2%

Icu Medical Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$1.4B	↑ 8.31%
Net Income	$28.8M	↓ 58.05%
Net Profit Margin	2.06%	↓ 3.25%

	FY19	Y/Y Change
Revenue	$1.3B	↓ 9.56%
Net Income	$101.0M	↑ 250.9%
Net Profit Margin	7.98%	↑ 5.92%

	FY20	Y/Y Change
Revenue	$1.3B	↑ 0.38%
Net Income	$86.9M	↓ 14.02%
Net Profit Margin	6.83%	↓ 1.15%

	FY21	Y/Y Change
Revenue	$1.3B	↑ 3.56%
Net Income	$103.1M	↑ 18.72%
Net Profit Margin	7.84%	↑ 1.01%

	FY22	Y/Y Change
Revenue	$2.3B	↑ 73.21%
Net Income	$-74.3M	↓ 172.03%
Net Profit Margin	-3.26%	↓ 11.1%

	FY23	Y/Y Change
Revenue	$2.3B	↓ 0.92%
Net Income	$-29.7M	↓ 60.08%
Net Profit Margin	-1.31%	↑ 1.95%

	Q2 FY23	Q/Q Change
Revenue	$549.3M	↓ 3.4%
Net Income	$-9.9M	↑ 1.24%
Net Profit Margin	-1.81%	↓ 0.08%

	Q3 FY23	Q/Q Change
Revenue	$553.3M	↑ 0.73%
Net Income	$7.2M	↓ 172.86%
Net Profit Margin	1.31%	↑ 3.12%

	Q4 FY23	Q/Q Change
Revenue	$588.0M	↑ 6.27%
Net Income	$-17.1M	↓ 336.9%
Net Profit Margin	-2.92%	↓ 4.23%

	Q1 FY24	Q/Q Change
Revenue	$566.0M	↓ 3.75%
Net Income	$-39.5M	↑ 130.19%
Net Profit Margin	-6.97%	↓ 4.05%

	Q2 FY24	Q/Q Change
Revenue	$596.5M	↑ 5.39%
Net Income	$-21.4M	↓ 45.77%
Net Profit Margin	-3.59%	↑ 3.38%

	Q3 FY24	Q/Q Change
Revenue	$589.1M	↓ 1.23%
Net Income	$-33.0M	↑ 54.08%
Net Profit Margin	-5.6%	↓ 2.01%

	FY18	Y/Y Change
Profit	$570.0M	↑ 33.78%

	FY19	Y/Y Change
Profit	$471.9M	↓ 17.22%

	FY20	Y/Y Change
Profit	$461.5M	↓ 2.2%

	FY21	Y/Y Change
Profit	$491.5M	↑ 6.5%

	FY22	Y/Y Change
Profit	$697.8M	↑ 41.97%

	FY23	Y/Y Change
Profit	$739.9M	↑ 6.04%

	Q2 FY23	Q/Q Change
Profit	$192.3M	↑ 0.15%

	Q3 FY23	Q/Q Change
Profit	$183.9M	↓ 4.37%

	Q4 FY23	Q/Q Change
Profit	$157.8M	↓ 14.2%

	Q1 FY24	Q/Q Change
Profit	$183.3M	↑ 16.13%

	Q2 FY24	Q/Q Change
Profit	$207.4M	↑ 13.19%

	Q3 FY24	Q/Q Change
Profit	$204.9M	↓ 1.24%

	FY18	Y/Y Change
Operating Cash Flow	$160.2M	↑ 3.75%
Investing Cash Flow	$-103.4M	↓ 61.27%
Financing Cash Flow	$8.0M	↓ 118.09%

	FY19	Y/Y Change
Operating Cash Flow	$101.9M	↓ 36.39%
Investing Cash Flow	$-166.9M	↑ 61.45%
Financing Cash Flow	$-10.9M	↓ 235.95%

	FY20	Y/Y Change
Operating Cash Flow	$222.8M	↑ 118.56%
Investing Cash Flow	$-98.1M	↓ 41.19%
Financing Cash Flow	$-40.0K	↓ 99.63%

	FY21	Y/Y Change
Operating Cash Flow	$267.5M	↑ 20.11%
Investing Cash Flow	$-90.7M	↓ 7.59%
Financing Cash Flow	$-16.9M	↑ 42075.0%

	FY22	Y/Y Change
Operating Cash Flow	$-62.1M	↓ 123.22%
Investing Cash Flow	$-1.9B	↑ 2005.56%
Financing Cash Flow	$1.6B	↓ 9803.81%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-1.5M	↓ 103.57%
Investing Cash Flow	$-17.6M	↑ 15.96%
Financing Cash Flow	$-5.9M	↓ 62.76%

Icu Medical Technicals Summary

Sell

Neutral

Buy

Icu Medical is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Icu Medical Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Icu Medical Inc	6.74%	30.45%	74.4%	-19.58%	-10.21%
Intuitive Surgical, Inc.	13.67%	38.33%	62.8%	131.11%	222.7%
Alcon Ag	3.14%	-4.92%	16.36%	19.6%	45.42%
West Pharmaceutical Services Inc	4.54%	22.16%	-1.79%	-8.06%	123.72%
Resmed Inc.	6.34%	25.52%	32.72%	6.53%	53.98%
Becton, Dickinson And Company	4.83%	0.26%	0.57%	-7.82%	-14.95%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Icu Medical Inc	356.69	NA	1.7	5.6	-0.05	0.01	NA	83.76
Intuitive Surgical, Inc.	97.13	97.13	4.38	6.92	0.16	0.08	NA	43.75
Alcon Ag	37.84	37.84	3.21	3.03	0.06	0.03	0.0	43.25
West Pharmaceutical Services Inc	51.22	51.22	6.28	6.63	0.18	0.1	0.0	37.96
Resmed Inc.	32.91	32.91	1.82	9.35	0.24	0.13	0.01	35.39
Becton, Dickinson And Company	40.67	40.67	1.09	14.35	0.06	0.03	0.02	89.47

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Icu Medical Inc	Buy	$4.1B	-10.21%	356.69	-4.74%
Intuitive Surgical, Inc.	Buy	$215.2B	222.7%	97.13	28.51%
Alcon Ag	Buy	$44.2B	45.42%	37.84	11.89%
West Pharmaceutical Services Inc	Buy	$25.0B	123.72%	51.22	17.37%
Resmed Inc.	Buy	$36.4B	53.98%	32.91	23.15%
Becton, Dickinson And Company	Buy	$69.0B	-14.95%	40.67	7.13%

About Icu Medical

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Organization	Icu Medical
Employees	14000
CEO	Mr. Vivek Jain
Industry	Health Technology

Management People of Icu Medical

Name	Title
Mr. Vivek Jain	CEO & Chairman of the Board
Mr. Daniel Woolson	President
Mr. Brian Michael Bonnell	CFO & Treasurer
Mr. Christian B. Voigtlander	Chief Operating Officer
Ms. Virginia Ruth Sanzone	Corporate VP, General Counsel, Secretary & Compliance Officer

Important FAQs about investing in Icu Medical (ICUI) from India :

What is Icu Medical share price today?

Icu Medical share price today stands at $167.12, Open: $165.93 ; Previous Close: $167.01 ; High: $167.15 ; Low: $162.38 ; 52 Week High: $196.26 ; 52 Week Low: $86.80. The stock opens at $165.93, after a previous close of $167.01. The stock reached a daily high of $167.15 and a low of $162.38, with a 52-week high of $196.26 and a 52-week low of $86.80.

Can Indians buy Icu Medical shares?

Yes, Indians can invest in the Icu Medical (ICUI) from India.

With INDmoney, you can buy Icu Medical at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Icu Medical at zero transaction cost.

How can I buy Icu Medical shares from India?

It is very easy to buy Icu Medical from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Icu Medical be purchased?

Yes, you can buy fractional shares of Icu Medical with INDmoney app.

What are the documents required to start investing in Icu Medical stocks?

To start investing in Icu Medical, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.